Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics of Acamprosate in Alcohol Use Disorder
NCT03818191Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2019
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acamprosate in alcohol use disorder (AUD), sponsored by Mayo Clinic. Started Jul 2019; status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03818191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818191.